Sign in

CIK 0001274737

  • Non-accelerated filer
  • Smaller reporting company

EXAGEN INC.

Sign in to watch
Ticker
XGN
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 760-560-1501
Business address
1261 LIBERTY WAY, VISTA, CA, 92081
Former names
EXAGEN DIAGNOSTICS INC
  1. 4 Exercise or conversion Chief Operating Officer acquired 1,934 shares (option exercise)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Chief Financial Officer acquired 37,500 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 37,500 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 50,000 shares (grant or award)
  6. 4 Open-market sale Director sold 3,000 shares at $17.00 ($51,000)
  7. 4 Open-market sale 10% owner sold 51,667 shares at an average $16.04 ($828,607)
  8. 4 Open-market sale 10% owner sold 110,000 shares at an average $16.04 ($1,764,738)
  9. 4 Open-market sale Director sold 1,271 shares at an average $15.52 ($19,723)
  10. 4 Open-market sale Director sold 5,729 shares at an average $15.63 ($89,534)
  11. 4 Open-market sale 10% owner sold 15,000 shares at $16.04 ($240,584)
  12. 4 Open-market sale 10% owner sold 32,580 shares at an average $16.05 ($522,965)
  13. 4 Open-market sale 10% owner sold 125,000 shares at $12.00 ($1,500,563)
  14. 4 Open-market sale Director sold 12,000 shares at $12.23 ($146,726)
  15. 4 Open-market sale Director sold 17,500 shares at an average $13.60 ($238,075)
  16. 4 Open-market sale 10% owner sold 15,947 shares at an average $16.05 ($255,965)
  17. 4 Open-market sale Director sold 882 shares at $16.21 ($14,293)
  18. 4 Open-market sale Director sold 6,618 shares at an average $15.35 ($101,577)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 6 of 9 · 168 filings